18980-21-7

Basic information

• Product Name: METHYL 3-ETHYL-4-HYDROXYBENZOATE
• Synonyms: 4-brom-2-aethylphenol;4-bromo-2-ethyl-pheno;METHYL 3-ETHYL-4-HYDROXYBENZOATE;2-Ethyl-4-bromophenol;4-Brom-2-aethylphenol [german];Brn 2413107;Einecs 242-718-9;Phenol, 4-bromo-2-ethyl-
• CAS NO: 18980-21-7
• Molecular Formula: C₈H₉BrO
• Molecular Weight: 201.06
• EINECS: 242-718-9
• Product Categories: Aromatics Compounds;Aromatics;Intermediates;Miscellaneous Reagents;Aromatics, Intermediates, Miscellaneous Reagents
• Mol File: 18980-21-7.mol
• Article Data: 14

Chemical Properties

• Melting Point: 37-39°C
• Boiling Point: 70-90°C 1mmHg.
• Flash Point: 108.7 °C
• Appearance: yellow solid
• Density: 1.469 g/cm³
• Vapor Pressure: 0.00979mmHg at 25°C
• Refractive Index: 1.577
• Storage Temp.: -20°C Freezer
• CAS DataBase Reference: METHYL 3-ETHYL-4-HYDROXYBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-ETHYL-4-HYDROXYBENZOATE(18980-21-7)
• EPA Substance Registry System: METHYL 3-ETHYL-4-HYDROXYBENZOATE(18980-21-7)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• RIDADR: UN 2811 6.1 / PGIII
• Hazardous Substances Data: 18980-21-7(Hazardous Substances Data)

Usage

Chemical Properties

Yellow Solid

InChI:InChI=1/C8H9BrO/c1-2-6-5-7(9)3-4-8(6)10/h3-5,10H,2H2,1H3

Upstream product

• 106-41-2 4-bromo-phenol 
• 1927-95-3 4-bromophenyl acetate 
• 1450-75-5 5-Bromo-2-hydroxyacetophenone 
• 90-00-6 o-Hydroxyethylbenzene 

Downstream Products

• 57704-12-8 5-bromo-3-ethylsalicylaldehyde 
• 105211-75-4 3-ethyl-4-hydroxybenzoic acid 
• 1257078-55-9 benzyl (4-bromo-2-ethylphenyl) ether 
• 877130-63-7 [2-(4-bromo-2-ethyl-phenoxy)-ethyl]-carbamic acid tert-butyl ester 
• 797784-50-0 1-(4-bromo-2-ethylphenoxy)propan-2-one 
• 666710-29-8 4-bromo-1-ethoxymethoxy-2-ethylbenzene 
• 221244-58-2 C₈H₉BrO₂ 
• 1062615-04-6 4-bromo-1-(difluoromethoxy)-2-ethylbenzene 
• 1016161-80-0 (4-bromo-2-ethylphenoxy)triisopropylsilane 
• 877131-60-7 2-(4-bromo-2-ethyl-phenoxy)-thiazole 

Relevant articles and documents

WDR5-MYC INHIBITORS

Substituted N-phenyl sulfonamide compounds inhibit WDR5-MYC interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject, such as cancer cell proliferation.

AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5- PHENYLIMIDAZOLONE COMPOUNDS AS ?-SECRETASE INHIBITORS

The present invention provides a 2-amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compound of formula (I) The present invention also provides methods for the use thereof to inhibit ?-secretase (BACE) and treat ?-amyloid deposits and neurofibrillary tangles.

INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME

The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).